Alaska Permanent Fund’s AstraZeneca AZN Stock Holding History

Alaska Permanent Fund’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$0	Hold	1	–	–	﹤0.01%	408
2022 Q3	$0	Hold	1	–	–	﹤0.01%	411
2022 Q2	$0	Sell	1 -15,294	-100%	-$2.01M	﹤0.01%	408
2022 Q1	$2.03M	Hold	15,295	–	–	0.03%	171
2021 Q4	$1.78M	Hold	15,295	–	–	0.03%	205
2021 Q3	$1.84M	Buy	+15,295	New	+$1.78M	0.04%	219

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alaska Permanent Fund's AZN Position: Q4 2022 in Review

Alaska Permanent Fund held its AstraZeneca (AZN) position steady in Q4 2022 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #408.

Alaska Permanent Fund first reported a position in AZN in Q3 2021 and has held it in 6 quarters since. The position peaked at $2.03M in Q1 2022. 1,061 funds tracked by Wall St. Rank hold AZN as of Q4 2022.

Alaska Permanent Fund held 1 share of AstraZeneca worth $0 as of Q4 2022.
Alaska Permanent Fund left its AstraZeneca share count unchanged in Q4 2022.
AstraZeneca made up ﹤0.01% of Alaska Permanent Fund's portfolio in Q4 2022, its #408 holding.
Alaska Permanent Fund first reported a position in AstraZeneca in Q3 2021 and has held it in 6 quarters since.
Alaska Permanent Fund's AstraZeneca position peaked at $2.03M in Q1 2022.
1,061 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2022.

Based on Alaska Permanent Fund's 13F filing for Q4 2022, filed 8 Feb 2023.